Adicet Bio Inc (ACET)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$2.92-5.81%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · ACET
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| Revenues | 5.2 | 5.8 | 10.7 | 10.0 | — | — | — | — | — |
| Operating Expenses & Income | |||||||||
| R&D Expenses | 83.8 | 99.1 | 99.3 | 106.0 | 71.2 | 48.9 | 34.3 | 23.7 | 14.7 |
| Other Operating Expenses, Total | 0.3 | 0.5 | 0.2 | 0.6 | — | — | — | — | — |
| Operating Income | (103.7) | (122.1) | (127.6) | (152.0) | (72.6) | (61.4) | (39.2) | (31.4) | (15.0) |
| Earnings from Continuing Operations | |||||||||
| Interest Expense | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.1 | — | — |
| Interest & Investment Income | — | — | — | — | — | — | — | 2.8 | — |
| Asset Writedown | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 |
| EBT, Incl. Unusual Items | (98.8) | (116.8) | (117.1) | (142.7) | (69.8) | (62.1) | (39.5) | (28.1) | (9.9) |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | (0.1) | (2.8) | 0.0 | (0.6) |
| Net Income | |||||||||
| Net Income | (99.0) | (116.8) | (117.1) | (142.7) | (69.8) | (62.0) | (36.7) | (28.1) | (9.3) |
| Per Share | |||||||||
| Basic EPS | (9.21) | (16.95) | (1.33) | (3.31) | (1.70) | (2.00) | — | — | — |
| Diluted EPS | (9.21) | (16.95) | (1.33) | (3.31) | (1.70) | (2.00) | — | — | — |
| Revenue per Share | 0.48 | — | — | — | — | — | — | — | — |
| Dividend per Share | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 |
| Basic Weighted Avg Shares | 10.7 | 6.9 | 87.9 | 43.0 | 41.1 | 31.0 | 7.3 | — | — |
| Diluted Weighted Avg Shares | 10.7 | 6.9 | 87.9 | 43.0 | 41.1 | 31.0 | — | — | — |
| Supplemental | |||||||||
| EBITDA | — | (115.7) | (121.1) | (145.9) | (70.0) | (59.9) | (38.0) | (30.2) | (13.7) |
| EBIT | (103.7) | (122.1) | (127.6) | (152.0) | (72.6) | (61.4) | (39.2) | (31.4) | (15.0) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | 0.2% | 7.1% | -0.1% | 6.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.